deramciclane has been researched along with 4-aminopyridine in 2 studies
| Studies (deramciclane) | Trials (deramciclane) | Recent Studies (post-2010) (deramciclane) | Studies (4-aminopyridine) | Trials (4-aminopyridine) | Recent Studies (post-2010) (4-aminopyridine) |
|---|---|---|---|---|---|
| 40 | 10 | 2 | 4,141 | 134 | 804 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kardos, J; Kovács, I; Nyitrai, G; Skuban, N | 1 |
| Kardos, J; Kovács, I; Skuban, N; Szárics, E | 1 |
2 other study(ies) available for deramciclane and 4-aminopyridine
| Article | Year |
|---|---|
Inhibition of [3H]D-aspartate release by deramciclane.
Topics: 4-Aminopyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Aspartic Acid; Camphanes; Cell Membrane; Cerebral Cortex; Depression, Chemical; Excitatory Amino Acid Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Male; Nerve Endings; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Rats; Rats, Wistar; Receptors, GABA-A; Tiagabine | 1999 |
Deramciclane inhibits N-methyl-D-aspartate receptor function.
Topics: 4-Aminopyridine; Animals; Anti-Anxiety Agents; Aspartic Acid; Benzodiazepines; Calcium; Camphanes; Cerebral Cortex; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Magnesium; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2000 |